Stocklytics Platform
Asset logo for symbol PHR
Phreesia
PHR54
$23.55arrow_drop_down8.33%-$2.14
Asset logo for symbol PHR
PHR54

$23.55

arrow_drop_down8.33%
Key Stats
Open$26.33
Prev. Close$25.69
EPS-1.78
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range23.55
26.41
52 Week Range12.05
30.70
Ratios
EPS-1.78
Fundamentals
Payout Ratio-
Industry average yield2.91%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

PHRarrow_drop_down8.33%
US Healthcare Sectorarrow_drop_down0.54%
US Marketarrow_drop_down1.02%
warning

PHR / Market

PHR lose to the US Market which returned -1.02% over the last twenty four hours.
warning

PHR / Healthcare Sector

PHR lose to the US Healthcare sector which returned -0.54% over the last twenty four hours.

Phreesia (PHR) Statistics

Phreesia Inc (PHR) is a healthcare technology company that provides a patient intake management platform. The company's platform automates the patient check-in process, streamlining administrative tasks and improving the patient experience. Phreesia's software collects patient information, verifies insurance eligibility, and collects payments, reducing the burden on front office staff and improving efficiency.
When looking at the valuation metrics for Phreesia Inc (PHR), it is important to consider factors such as the company's market capitalization, price-to-earnings ratio, and price-to-sales ratio. These metrics can help investors gain insight into the company's value relative to its earnings and revenue. Additionally, the fundamentals of Phreesia Inc (PHR) should be analyzed to assess factors such as the company's profitability, debt levels, and gross profit. This information can provide a comprehensive picture of the company's financial health.
add Phreesia  to watchlist

Keep an eye on Phreesia

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Phreesia (PHR) stock's performance compared to its sector and the market over the past year?

Over the past year, Phreesia (PHR) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 25.97%, Phreesia has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 58.78%, it has fallen short of the market average. This comparison highlights Phreesia 's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Phreesia (PHR) stock?

The PE ratio for Phreesia (PHR) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help

What is the EPS of Phreesia (PHR) stock?

The Earnings Per Share (EPS) for Phreesia (PHR), calculated on a diluted basis, is -$1.63. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Phreesia (PHR) stock?

The operating margin for Phreesia (PHR) is -46.68%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Phreesia (PHR) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Phreesia (PHR) is -$73.39M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Phreesia (PHR) have?

Phreesia (PHR) has a total debt of $12.64M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$65.28M.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media